05 November 2013

Don’t Miss the Cutting-Edge Sessions at the WAO Symposium

Register today for the WAO Symposium on Immunotherapy and Biologics and attend cutting-edge sessions.

Click here to view the full Online Scientific Program of the Symposium.

Scientific Program Highlights

Immunotherapy Track 5: Social Consequences and Evidence Based Medicine and Immunotherapy
Saturday, 14 December
10:00 - 11:30 

The Consolidated Standards of Reporting Trials (CONSORT) Statement Applied to Allergen-Specific Immunotherapy with Inhalant Allergens
Jan Brozek (Canada)
Recent Publication: Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study

Pharmacoeconomics of Immunotherapy
Cheryl Hankin (United States)
Recent Publication: Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis

 

Selection of Patients for Sublingual versus Subcutaneous Immunotherapy
Désirée Larenas-Linnemann (Mexico)
Recent Publication: Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012

 

 

Biologics Track 5: Biomarkers, Biosimilars and Selection of Patients
Saturday, 14 December
10:00 - 11:30 

The Use of Biomarkers in Asthma Clinical Research Trials
Robert Lemanske (United States)
Recent Publication: Asthma outcomes: biomarkers

 
 

Inner City Asthma and Anti-IgE
William Busse (United States)
Recent Publication: Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children


 

State of the Art on Biosimilars
Sergio Bonini (Italy)
Recent Publication: Regulatory aspects of allergen-specific immunotherapy: Europe sets the scene for a global approach